Therefore, there is a pressing need to develop strategies to increase tumor antigen-specific CD8+ T-cell infiltration and turn “cold tumors” (such as colon and breast cancers) into “hot tumors” for effective immune therapy. This evidence concerns the gene CD8A and breast carcinoma.